 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: AVI-4658 | Exondys 51®
                                 eteplirsen is an approved drug (FDA (2016)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Eteplirsen is a novel oligonucleotide drug for the treatment of Duchenne muscular dystrophy (DMD), caused by specific reading frame mutations in the dystrophin gene [2]. Structurally it is a 30 base morpholino antisense oligomer in which a six-membered morpholine ring replaces the ribose sugars, and a phosphorodiamidate group replaces the normal anionic phosphodiester links between bases. This type of nucleotide is sometimes referred to as a phosphorodiamidate morpholino oligo, or PMO.  While the size of this causes molecular indexing  and rendering problems, two images of the chemical structure were found. The first  from the NIH US National Library of Medicine where they provide the InChIKey KZOVCSBYYXUVDW-UHFFFAOYSA-N. The second is ChemSpider  34983391 with a different InChIKey GHBMWAGCLOEKQK-BMBJILFMSA-N.
                                    
                                 | 
| Classification  | |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. US FDA (2016) | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 9339 | eteplirsen | 
| Synonyms  | 
| AVI-4658 | Exondys 51® | 
| Database Links  | |
| ChEMBL Ligand | CHEMBL2108278 | 
| GtoPdb PubChem SID | 187051835 | 
| Search PubMed clinical trials | eteplirsen | 
| Search PubMed titles | eteplirsen | 
| Search PubMed titles/abstracts | eteplirsen | 
| Wikipedia | Eteplirsen |